On the public citation graph
A Class of Sulfonamides with Strong Inhibitory Action against the α-Carbonic Anhydrase from Trypanosoma cruzi
0 signed · 109 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jps.23010openalex-snapshot
First Century of Chagas' Disease: An Overview on Novel Approaches to Nifurtimox and Benznidazole Delivery Systems
inferredcites →https://doi.org/10.1006/jmbi.1996.0897openalex-snapshot
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
inferredcites →https://doi.org/10.1006/jmbi.1998.2077openalex-snapshot
Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide
inferredcites →https://doi.org/10.1007/s00436-006-0126-yopenalex-snapshot
Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes
inferredcites →https://doi.org/10.1016/j.bmc.2004.10.015openalex-snapshot
Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
inferredcites →https://doi.org/10.1016/j.bmc.2009.01.048openalex-snapshot
Carbonic anhydrase inhibitors. The nematode α-carbonic anhydrase of Caenorhabditis elegans CAH-4b is highly inhibited by 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides
inferredcites →https://doi.org/10.1016/j.bmc.2009.06.006openalex-snapshot
Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB
inferredcites →https://doi.org/10.1016/j.bmcl.2010.05.009openalex-snapshot
Carbonic anhydrase inhibitors
inferredcites →https://doi.org/10.1016/j.molbiopara.2008.06.013openalex-snapshot
External pH influences the transcriptional profile of the carbonic anhydrase, CAH-4b in Caenorhabditis elegans
inferredcites →https://doi.org/10.1016/s0021-9258(18)62326-9openalex-snapshot
The Carbon Dioxide Hydration Activity of Carbonic Anhydrase
inferredcites →https://doi.org/10.1021/cr200176ropenalex-snapshot
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
inferredcites →https://doi.org/10.1021/jm001051+openalex-snapshot
Carbonic Anhydrase Inhibitors: Water-Soluble 4-Sulfamoylphenylthioureas as Topical Intraocular Pressure-Lowering Agents with Long-Lasting Effects
inferredcites →https://doi.org/10.1021/jm4000616openalex-snapshot
Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease
inferredcites →https://doi.org/10.1038/nrd2467openalex-snapshot
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
inferredcites →https://doi.org/10.1038/nrd3554openalex-snapshot
Interfering with pH regulation in tumours as a therapeutic strategy
inferredcites →https://doi.org/10.1039/b926832dopenalex-snapshot
The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I–topiramate complex
inferredcites →https://doi.org/10.1039/c0cc02707copenalex-snapshot
Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency
inferredcites →https://doi.org/10.1039/c1cc14575dopenalex-snapshot
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II
inferredcites →https://doi.org/10.1039/c2cc16395kopenalex-snapshot
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations
inferredcites →https://doi.org/10.1039/c2cc30359kopenalex-snapshot
Serendipitous fragment-based drug discovery: ketogenic diet metabolites and statins effectively inhibit several carbonic anhydrases
inferredcites →https://doi.org/10.1039/c2cc33415aopenalex-snapshot
Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases
inferredcites →https://doi.org/10.1371/journal.pone.0052205openalex-snapshot
In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity
inferredcites →https://doi.org/10.1517/13543776.2012.649006openalex-snapshot
Novel therapies for glaucoma: a patent review 2007 – 2011
inferredcites →https://doi.org/10.1517/13543776.2013.742065openalex-snapshot
Secondary and tertiary sulfonamides: a patent review (2008 – 2012)
inferredcites →https://doi.org/10.1517/13543776.2013.778245openalex-snapshot
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
inferredcites →https://doi.org/10.1517/13543776.2013.778246openalex-snapshot
Carbonic anhydrase inhibitors: an editorial
inferredcites →https://doi.org/10.1517/13543776.2013.794788openalex-snapshot
Antiglaucoma carbonic anhydrase inhibitors: a patent review
inferredcites →https://doi.org/10.1590/s0037-86822012000300002openalex-snapshot
Chagas disease: What is known and what should be improved: a systemic review
inferredcites →https://doi.org/10.2174/156802607780636735openalex-snapshot
The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents
inferredcites →https://doi.org/10.3109/14756366.2011.597749openalex-snapshot
A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology
inferredcites →https://doi.org/10.3109/14756366.2012.672983openalex-snapshot
Structure-based drug discovery of carbonic anhydrase inhibitors
inferredcites →https://doi.org/10.3389/fphar.2011.00034openalex-snapshot
Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4057421openalex-extracted
An Efficient Synthesis of 4-Thiocyanato Anilines Using Benzyltrimethylammonium Dichloroiodate and Ammonium Thiocyanate in Dmso:H2o
inferred← citeshttps://doi.org/10.1002/ardp.202400626openalex-snapshot
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases
inferred← citeshttps://doi.org/10.1002/cbdv.202501477openalex-snapshot
Design, Synthesis, Biological Evaluation, and In Silico Analysis of Novel Antifungal Agents Targeting Trichophyton Species
inferred← citeshttps://doi.org/10.1002/jhet.4240openalex-snapshot
Convergent synthesis of carbonic anhydrase inhibiting bi‐heterocyclic benzamides: Structure–activity relationship and mechanistic explorations through enzyme inhibition, kinetics, and computational studies
inferred← citeshttps://doi.org/10.1002/med.22115openalex-snapshot
Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research
inferred← citeshttps://doi.org/10.1007/7355_2021_129openalex-snapshot
η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials
inferred← citeshttps://doi.org/10.1007/7355_2021_138openalex-snapshot
Beta-Carbonic Anhydrase 1 from Trichomonas Vaginalis as New Antiprotozoan Drug Target
inferred← citeshttps://doi.org/10.1007/7355_2021_140openalex-snapshot
Targeting Carbonic Anhydrases from Trypanosoma cruzi and Leishmania spp. as a Therapeutic Strategy to Obtain New Antiprotozoal Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-816476-1.00020-4openalex-snapshot
Carbonic anhydrases from pathogens
inferred← citeshttps://doi.org/10.1016/b978-0-444-63258-6.00007-xopenalex-snapshot
The Structure, Physiological Role, and Potential Medicinal Applications of Carbonic Anhydrase V
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.04.002openalex-snapshot
Sordaria macrospora carbonic anhydrases
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.05.001openalex-snapshot
Overview on fungal and protozoan carbonic anhydrases
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.05.003openalex-snapshot
Trypanosoma cruzi and Leishmania spp. CAs
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.05.004openalex-snapshot
Toxoplasma gondii, babesia, and other protozoan carbonic anhydrases
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.05.005openalex-snapshot
Challenges for developing selective fungal/protozoal carbonic anhydrase inhibitors as anti-infectives
inferred← citeshttps://doi.org/10.1016/bs.pmch.2014.12.001openalex-snapshot
A New Era for Chagas Disease Drug Discovery?
inferred← citeshttps://doi.org/10.1016/j.actatropica.2026.108007openalex-snapshot
Acetazolamide as a novel therapeutic agent against acute experimental toxoplasmosis: Insights into carbonic anhydrase inhibition
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.10.042openalex-snapshot
Synthesis of 1,2,4-triazole-5-on derivatives and determination of carbonic anhydrase II isoenzyme inhibition effects
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.01.002openalex-snapshot
Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2014.04.007openalex-snapshot
Oxidation of cyanobenzocycloheptatrienes: Synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.03.068openalex-snapshot
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.03.081openalex-snapshot
The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.10.006openalex-snapshot
Poly(amidoamine) dendrimers show carbonic anhydrase inhibitory activity against α-, β-, γ- and η-class enzymes
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.05.029openalex-snapshot
Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.07.034openalex-snapshot
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.11.027openalex-snapshot
Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.01.034openalex-snapshot
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.08.047openalex-snapshot
Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.10.037openalex-snapshot
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.08.014openalex-snapshot
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.09.076openalex-snapshot
Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.04.064openalex-snapshot
Identification and preliminary structure-activity relationship studies of novel pyridyl sulfonamides as potential Chagas disease therapeutic agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2023.129411openalex-snapshot
A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.150985openalex-snapshot
Trypanosoma cruzi carbonic anhydrase inhibitors as a potential antiparasitic agent
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2014.02.002openalex-snapshot
Drug repurposing and human parasitic protozoan diseases
inferred← citeshttps://doi.org/10.1016/j.molstruc.2021.131886openalex-snapshot
Antitumor activity, X-Ray crystallography, in silico study of some-sulfamido-phosphonates. Identification of pharmacophore sites
inferred← citeshttps://doi.org/10.1016/j.tet.2020.131662openalex-snapshot
Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances
inferred← citeshttps://doi.org/10.1016/j.tetlet.2022.153809openalex-snapshot
An efficient synthesis of 4-Thiocyanato anilines using benzyltrimethylammonium dichloroiodate and ammonium thiocyanate in DMSO:H2O
inferred← citeshttps://doi.org/10.1016/s0140-6736(25)01196-1openalex-snapshot
Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01720openalex-snapshot
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c01234openalex-snapshot
Exploring Privileged Structure Repurposing: Target Similarity as a Catalyst for Cross-Species Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00183openalex-snapshot
Lead Development of Thiazolylsulfonamides with Carbonic Anhydrase Inhibitory Action
inferred← citeshttps://doi.org/10.1021/acscombsci.8b00044openalex-snapshot
Current Parallel Solid-Phase Synthesis of Drug-like Oxadiazole and Thiadiazole Derivatives for Combinatorial Chemistry
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00430openalex-snapshot
N-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis
inferred← citeshttps://doi.org/10.1021/jm501314copenalex-snapshot
Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity, and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups
inferred← citeshttps://doi.org/10.1021/jm501497mopenalex-snapshot
A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects
inferred← citeshttps://doi.org/10.1080/14756366.2016.1217856openalex-snapshot
Cloning, expression and purification of the complete domain of theη-carbonic anhydrase fromPlasmodium falciparum
inferred← citeshttps://doi.org/10.1080/14756366.2017.1380638openalex-snapshot
Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors
inferred← citeshttps://doi.org/10.1080/14756366.2017.1405264openalex-snapshot
Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
inferred← citeshttps://doi.org/10.1080/14756366.2017.1414808openalex-snapshot
Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles
inferred← citeshttps://doi.org/10.1080/14756366.2018.1463221openalex-snapshot
Antileishmanial activity of sulphonamide nanoemulsions targeting theβ-carbonic anhydrase fromLeishmaniaspecies
inferred← citeshttps://doi.org/10.1080/14756366.2018.1491564openalex-snapshot
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates
inferred← citeshttps://doi.org/10.1080/14756366.2018.1559840openalex-snapshot
Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
inferred← citeshttps://doi.org/10.1080/14756366.2019.1626375openalex-snapshot
Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani
inferred← citeshttps://doi.org/10.1080/14756366.2019.1677638openalex-snapshot
A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors
inferred← citeshttps://doi.org/10.1080/14756366.2024.2346523openalex-snapshot
Cloning, expression, and purification of an α-carbonic anhydrase from Toxoplasma gondii to unveil its kinetic parameters and anion inhibition profile.
inferred← citeshttps://doi.org/10.1080/17460441.2019.1567488openalex-snapshot
Novel approaches for designing drugs that interfere with pH regulation
inferred← citeshttps://doi.org/10.1080/17460441.2022.2117295openalex-snapshot
Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?
inferred← citeshttps://doi.org/10.1111/cbdd.70025openalex-snapshot
Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
inferred← citeshttps://doi.org/10.1517/14728222.2015.1067685openalex-snapshot
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
inferred← citeshttps://doi.org/10.2174/0109298673249553231018070920openalex-snapshot
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents
inferred← citeshttps://doi.org/10.2174/0115734064310458240719071823openalex-snapshot
A Computational Approach Using α-Carbonic Anhydrase to Find Anti-Trypanosoma cruzi Agents
inferred← citeshttps://doi.org/10.2174/9789815324785125010006openalex-snapshot
Chagas Diseases: State of the Art and New Perspectives
inferred← citeshttps://doi.org/10.25904/1912/3440openalex-snapshot
Investigating the Potential of Primary Sulfonamides as Antimalarial Drug Leads
inferred← citeshttps://doi.org/10.3109/14756366.2014.1002403openalex-snapshot
A failed tentative to design a super carbonic anhydrase having the biochemical properties of the most thermostable CA (SspCA) and the fastest (SazCA) enzymes
inferred← citeshttps://doi.org/10.3109/14756366.2014.917085openalex-snapshot
Protonography, a new technique for the analysis of carbonic anhydrase activity
inferred← citeshttps://doi.org/10.3109/14756366.2014.956309openalex-snapshot
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase fromTrypanosoma cruzi
inferred← citeshttps://doi.org/10.3109/14756366.2014.990963openalex-snapshot
Protonography, a technique applicable for the analysis ofη-carbonic anhydrase activity
inferred← citeshttps://doi.org/10.3389/fmolb.2024.1338528openalex-snapshot
Carbonic anhydrase, its inhibitors and vascular function
inferred← citeshttps://doi.org/10.3390/ijms26010116openalex-snapshot
Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting
inferred← citeshttps://doi.org/10.3390/molecules27228028openalex-snapshot
Design, Synthesis and Biological Assessment of Rhodanine-Linked Benzenesulfonamide Derivatives as Selective and Potent Human Carbonic Anhydrase Inhibitors
inferred← citeshttps://doi.org/10.3390/ph16060901openalex-snapshot
Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites
inferred← citeshttps://doi.org/10.3390/ph18050669openalex-snapshot
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in Trypanosoma cruzi: Virtual Screening and In Vitro Studies
inferred← citeshttps://doi.org/10.3390/reactions3010014openalex-snapshot
N-4 Alkyl Cytosine Derivatives Synthesis: A New Approach
inferred← citeshttps://doi.org/10.4155/fmc.15.185openalex-snapshot
Inhibition of Carbonic Anhydrase from Trypanosoma Cruzi for the Management of Chagas Disease: An Underexplored Therapeutic Opportunity
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.